Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8 + cytotoxic T lymphocytes (Q40760425)
scientific article published on November 1, 2001
Language:
(P31) (Q13442814)
(P304) 445-455
(P407) (Q1860)
(P433) 9
(P478) 50
(P577) Thursday, November 1, 2001
Thursday, November 1, 2001
(P921) (Q246181)
(Q715347)
(Q18554829)
(P953) https://europepmc.org/articles/PMC11034323
https://europepmc.org/articles/PMC11034323?pdf=render
https://doi.org/10.1007/s002620100229
http://link.springer.com/content/pdf/10.1007/s002620100229.pdf
http://link.springer.com/article/10.1007/s002620100229/fulltext.html
http://link.springer.com/content/pdf/10.1007/s002620100229
(P1433) (Q5031409)
(P1476) "Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes" (language: en)
"Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8 + cytotoxic T lymphocytes" (language: en)
(P2093) E. S. Bergmann-Leitner
S. I. Abrams
other details
description scientific article published on November 1, 2001

External Links